• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肉芽肿病患者发生霉菌感染时造血细胞移植的结局

Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease.

作者信息

Kline Ahnika, Parta Mark, Cuellar-Rodriguez Jennifer, Gea-Banacloche Juan, Kelly Corin, Pittaluga Stefania, Zerbe Christa S, Holland Steven M, Malech Harry L, Kang Elizabeth M

机构信息

Department of Laboratory Medicine/National Institutes of Health, San Diego, CA, USA.

Clinical Research Directorate, Frederick National Laboratory for Cancer Research, San Diego, CA, USA.

出版信息

Bone Marrow Transplant. 2025 Feb;60(2):191-200. doi: 10.1038/s41409-024-02389-x. Epub 2024 Nov 4.

DOI:10.1038/s41409-024-02389-x
PMID:39496936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11810765/
Abstract

Chronic granulomatous disease (CGD) is a disorder of immunity characterized by phagocyte dysfunction. Mold infections in patients with CGD are often severe and disseminated. We present patient characteristics, microbiological data, and outcomes for 26 patients with CGD who received hematopoietic cell transplantation (HCT) or gene therapy-modified cells (GT) between 2008 and 2019, with proven fungal infection either before or during their transplant. All patients engrafted, and all but one GT recipient had neutrophil recovery and evidence of functional correction. Eighteen patients (69%) are currently alive and 19 patients (73% of total, 90% of patients with repeat imaging performed) had evidence of radiographic improvement. With 3 exceptions, deaths were not principally related to the fungal infection and duration of antecedent infection did not correlate with death. Aspergillus species accounted for the majority of disease (50%), followed by Phellinus species (18%). Osteomyelitis and disseminated disease were common, as only 11 patients (42%) had disease restricted to pneumonia. Triazole therapy was used in all 26 patients, with combination therapy used in 25 (96%). HCT or gene therapy, with appropriate antifungal therapy, are viable therapies for refractory fungal infections in patients with CGD.

摘要

慢性肉芽肿病(CGD)是一种以吞噬细胞功能障碍为特征的免疫紊乱疾病。CGD患者的霉菌感染往往严重且呈播散性。我们呈现了2008年至2019年间接受造血细胞移植(HCT)或基因治疗修饰细胞(GT)的26例CGD患者的患者特征、微生物学数据及转归情况,这些患者在移植前或移植期间已证实有真菌感染。所有患者均实现植入,除1例GT接受者外,所有患者中性粒细胞均恢复且有功能纠正的证据。18例患者(69%)目前存活,19例患者(占总数的73%,在进行重复影像学检查的患者中占90%)有影像学改善的证据。除3例例外,死亡主要与真菌感染无关,既往感染持续时间与死亡无相关性。曲霉菌属占疾病的大多数(50%),其次是桑黄菌属(18%)。骨髓炎和播散性疾病很常见,只有11例患者(42%)疾病局限于肺炎。所有26例患者均使用了三唑类治疗,25例(96%)使用了联合治疗。HCT或基因治疗联合适当的抗真菌治疗是CGD患者难治性真菌感染的可行治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fb8/11810765/1476e1b69a04/41409_2024_2389_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fb8/11810765/f12d165743ad/41409_2024_2389_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fb8/11810765/1476e1b69a04/41409_2024_2389_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fb8/11810765/f12d165743ad/41409_2024_2389_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fb8/11810765/1476e1b69a04/41409_2024_2389_Fig2_HTML.jpg

相似文献

1
Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease.慢性肉芽肿病患者发生霉菌感染时造血细胞移植的结局
Bone Marrow Transplant. 2025 Feb;60(2):191-200. doi: 10.1038/s41409-024-02389-x. Epub 2024 Nov 4.
2
Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.慢性肉芽肿病中的侵袭性霉菌感染:一项 25 年回顾性调查。
Clin Infect Dis. 2011 Dec;53(12):e159-69. doi: 10.1093/cid/cir731.
3
Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.日本慢性肉芽肿病的造血细胞移植。
Front Immunol. 2020 Jul 29;11:1617. doi: 10.3389/fimmu.2020.01617. eCollection 2020.
4
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.慢性肉芽肿病相关炎症性肠病在异基因造血干细胞移植后缓解,且不会对生存造成不利影响。
J Clin Immunol. 2019 Oct;39(7):653-667. doi: 10.1007/s10875-019-00659-8. Epub 2019 Aug 2.
5
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium study.同种异体造血细胞移植治疗 p47phox 慢性肉芽肿病有效:原发性免疫缺陷治疗联盟研究。
J Allergy Clin Immunol. 2024 May;153(5):1423-1431.e2. doi: 10.1016/j.jaci.2024.01.013. Epub 2024 Jan 28.
6
Phellinus species: An emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease.桑黄属物种:X连锁慢性肉芽肿病患者难治性真菌感染的新出现病因。
Mycoses. 2017 Mar;60(3):155-160. doi: 10.1111/myc.12573. Epub 2016 Oct 26.
7
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.通过粒细胞输注继以外周血干细胞移植成功治疗慢性肉芽肿病中的侵袭性曲霉病。
Bone Marrow Transplant. 2000 Nov;26(9):1025-8. doi: 10.1038/sj.bmt.1702651.
8
Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment.慢性肉芽肿病-造血干细胞移植与常规治疗。
Acta Paediatr. 2013 Nov;102(11):1087-94. doi: 10.1111/apa.12384. Epub 2013 Sep 10.
9
Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.异基因造血干细胞移植治疗慢性肉芽肿病(CGD):美国免疫缺陷网络报告。
J Clin Immunol. 2019 May;39(4):448-458. doi: 10.1007/s10875-019-00635-2. Epub 2019 May 20.
10
Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.异基因造血细胞移植治疗慢性肉芽肿病:争议与现状。
J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S31-S39. doi: 10.1093/jpids/piy015.

引用本文的文献

1
Invasive Mould Infections in Chronic Granulomatous Disease: A Multicenter Study From Türkiye.慢性肉芽肿病中的侵袭性霉菌感染:来自土耳其的一项多中心研究。
Mycoses. 2025 Jul;68(7):e70086. doi: 10.1111/myc.70086.
2
Mold infections in chronic granulomatous disease patients-what comes to the rescue?慢性肉芽肿病患者的霉菌感染——如何应对?
Bone Marrow Transplant. 2025 Feb;60(2):180-181. doi: 10.1038/s41409-024-02342-y. Epub 2024 Nov 4.

本文引用的文献

1
Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.发热性中性粒细胞减少症在慢性肉芽肿病造血细胞移植中的管理和结局。
Transpl Infect Dis. 2022 Apr;24(2):e13815. doi: 10.1111/tid.13815. Epub 2022 Mar 10.
2
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?2020年异基因造血细胞移植受者的侵袭性霉菌感染:我们是否取得了足够的进展?
Open Forum Infect Dis. 2021 Nov 29;9(1):ofab596. doi: 10.1093/ofid/ofab596. eCollection 2022 Jan.
3
The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder.
黏膜微生物群、结肠炎与慢性肉芽肿病中的系统性炎症之间的关系。
J Clin Immunol. 2022 Feb;42(2):312-324. doi: 10.1007/s10875-021-01165-6. Epub 2021 Nov 3.
4
Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.异基因细胞移植后侵袭性霉菌感染管理中抗真菌治疗联合用药的实际考量
J Fungi (Basel). 2021 Sep 28;7(10):811. doi: 10.3390/jof7100811.
5
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).血液学重要突变:常染色体慢性肉芽肿病(第三次更新)。
Blood Cells Mol Dis. 2021 Dec;92:102596. doi: 10.1016/j.bcmd.2021.102596. Epub 2021 Jul 28.
6
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).血液学重要突变:X 连锁慢性肉芽肿病(第四次更新)。
Blood Cells Mol Dis. 2021 Sep;90:102587. doi: 10.1016/j.bcmd.2021.102587. Epub 2021 Jun 2.
7
Hematopoietic Stem Cell Transplantation Cures Therapy-refractory Aspergillosis in Chronic Granulomatous Disease.造血干细胞移植治愈慢性肉芽肿病治疗抵抗性曲霉病。
Pediatr Infect Dis J. 2021 Jul 1;40(7):649-654. doi: 10.1097/INF.0000000000003109.
8
Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.在采用移植后环磷酰胺的大规模单倍体造血干细胞移植中,严重感染和感染相关死亡率。
Bone Marrow Transplant. 2021 Oct;56(10):2432-2444. doi: 10.1038/s41409-021-01328-4. Epub 2021 May 31.
9
Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection.造血干细胞移植治疗确诊或疑似侵袭性真菌感染预处理后混合反应患者的结局。
Transplant Cell Ther. 2021 Aug;27(8):684.e1-684.e9. doi: 10.1016/j.jtct.2021.04.021. Epub 2021 May 5.
10
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.泊沙康唑与伏立康唑治疗侵袭性曲霉病的随机对照 3 期非劣效临床试验
Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140-6736(21)00219-1.